The capacity of various mycoplasma strains and species to induce lymphocyte transformation in vitro was studied. Of six strains of Mycoplasma pulmonis studied, five displayed mitogenic activity with rat lymphocytes. Among those M. pulmonis strains, our MP15 isolate and the Negroni strain exhibited particularly potent mitogenic capacity. The murine mycoplasmas M. neurolyticum and M. arthritidis shared this mitogenicity for rat lymphocytes. However, the human mycoplasmas M. fermentans, M. pneumoniae, M. hominis, M. orale, and Acholeplasma laidlawii did not activate rat lymphocytes. Lymphocytes obtained from germfree rats were activated to the same extent as those from animals bred under conventional conditions. The mitogenic potency exhibited by mycoplasma was not restricted to infective microorganisms, and preparations of killed mycoplasma particles exerted an extensive lymphocyte transformation. The data show that the mitogenic activity of mycoplasmas is not confined to a single mycoplasma isolate and that it acts in a nonspecific manner.
The capacity of various mycoplasma strains and species to induce lymphocyte transformation in vitro was studied. Of six strains of Mycoplasma pulmonis studied, five displayed mitogenic activity with rat lymphocytes. Among those M. pulmonis strains, our MP15 isolate and the Negroni strain exhibited particularly potent mitogenic capacity. The murine mycoplasmas M. neurolyticum and M. arthritidis shared this mitogenicity for rat lymphocytes. However, the human mycoplasmas M. fermentans, M. pneumoniae, M. hominis, M. orale, and Acholeplasma laidlawii did not activate rat lymphocytes. Lymphocytes obtained from germfree rats were activated to the same extent as those from animals bred under conventional conditions. The mitogenic potency exhibited by mycoplasma was not restricted to infective microorganisms, and preparations of killed mycoplasma particles exerted an extensive lymphocyte transformation. The data show that the mitogenic activity of mycoplasmas is not confined to a single mycoplasma isolate and that it acts in a nonspecific manner.
Various agents are known to be capable of inducing the transformation of lymphocytes into blast cells (18) . Most of these agents, commonly referred to as "mitogens," are plant lectins. Streptolysin S (15) and staphylococcal filtrate (17) , which induce transformation in human lymphocytes, and lipopolysaccharides of gramnegative bacteria, which induce the transformation of mouse lymphocytes (18) , are among the few mitogens that have been isolated from microorganisms. These mitogens are considered to be nonspecific in their action since (i) they activate a large proportion of the lymphocyte population obtained from normal untreated or germfree animals and (ii) they stimulate lymphocytes obtained from newborn and therefore unprimed individuals (14) .
It is not clear whether nonspecific mitogeninduced lymphocyte stimulation should be looked upon as an artifact of in vitro studies or whether it is a genuine immune mechanism operating against infection. Differentiation between these two possibilities should be feasible in a system in which mitogenic stimulation of lymphocytes by a living infectious microorganism can be obtained in vitro. We have previously described such a system in which Mycoplasma pulmonis displays very strong mitogenic activity for rat lymphocytes in vitro. Our studies (11; H. Ginsburg, Isr. J. Med. Sci. 10:1165, 1974) have indicated that this mitogenic activity may provide a model for the study of the interrelationship between immunocompetent cells and a pathogenic microorganism and the possible relationship between the pathogenicity of a microorganism and its mitogenic activity. To further pursue these studies, it was necessary to determine whether mitogenicity toward rat lymphocytes is a common property of various mycoplasma strains and species or whether it is restricted to our M. pulmonis isolate. In addition, further experimentation was required to determine whether the mitogenic activity of mycoplasma(s) is indeed nonspecific and not a result of prior infection.
In studies reported here, we demonstrate that certain strains of M. pulmonis and other murine mycoplasmas, M. neurolyticum and M. arthritidis, are strong mitogens for rat lymphocytes. Various human mycoplasmas, on the other hand, did not stimulate murine lymphocytes.
MATERIALS AND METHODS
Animals. Two-month-old male and female Charles River random-bred rats were obtained from a local farm. Germfree Charles River CD(SD) GN female rats 8 weeks old were purchased from Charles River Mouse Fanns Inc., Wilmington, Mass. Mycoplasmas. The murine M. pulmonis isolated by us and found to be mitogenic for rat lymphocytes (11) Growth of mycoplasmas. The mycoplasmas were grown in a broth medium modified from the one described by Hayflick (13) . This broth consisted of (per liter): PPLO broth without crystal violet (Difco), 24 g; glucose, 10 g; K2HPO4, 2.4 g; deoxyribonucleic acid (sodium salt), 0.05 g; thalium acetate, 0.25 g; and penicillin G, 500,000 U. The broth was supplemented with 20% horse serum and 10% fresh 25% Fleischmann yeast extract. The pH of the broth was adjusted to 7.8 to 8.0. Agar medium was prepared with PPLO agar instead of PPLO broth. The cultures were incubated aerobically at 37°C for 2 to 3 days except for those of the more fastidious mycoplasmas, which were incubated for 5 to 7 days. All mycoplasma strains and species were passaged in broth and then cloned on the agar medium, and an isolate of a single colony was then grown in broth. The suspensions formed were stored at -750C. Embryo fibroblast cultures. Fibroblast monolayers were prepared from 1.5-cm -long rat embryos as previously described (9, 12) . Briefly, 1 x 106 to 2 x 106 cells in 4 ml of Waymouth medium supplemented with 5% calf serum were plated in 60-mm Falcon plastic petri dishes (Falcon Plastics, Los Angeles, Calif.) and incubated for 2 days before use.
Titration of mycoplasmas. Mycoplasma titers are expressed as either number of colony-forming units (CFU) or color-changing units per milliliter. CFU were titrated by making 10-fold serial dilutions of a mycoplasma suspension in broth and plating 0.1-ml samples on agar plates. Colonies were counted after 7 days of incubation. Color-changing units were titrated by inoculation of 2-day-old embryo fibroblast monolayers with 0.1 ml of a mycoplasma suspension. The highest dilution that lowered the pH of half of the fibroblast cultures was designated as 1 color-changing unit. The change in pH indicated by the change in color of the phenol red indicator present in the culture medium is attributable to the fermentation of glucose by the growing mycoplasma in the cultures (2, 23) .
Lymphocyte suspensions. Rat lymphocytes were prepared from spleen or lymph nodes as previously described (9, 12) . A total of 107 cells in 5 ml of Dulbecco medium + 15% horse serum (heat inactivated at 560C for 30 min) were plated onto either 2-day-old monolayers of embryo fibroblasts or similar petri dishes devoid of monolayers.
Mitogens. Mycoplasma cells were lysed by combining osmotic treatment with digitonin as described by Razin and Rottem (21) . Briefly, 3-to 4-day-old broth cultures were centrifuged at 10,000 x g for 20 5 Ci/mmol) and by calculating the blast cell-to-lymphocyte ratio with a Coulter Counter (3, 10) . For measuring thymidine uptake, 1-ml samples of lymphoid cell suspensions or parallel samples of lymphocytefree culture medium of control cultures were collected from monolayers by gentle pipetting and incubated in 1-ml test tubes with 1 ,uCi of [3H]thymidine per ml at 37°C for 3 h (if not otherwise specified). After the incubation both the cell suspensions and control samples were centrifuged at 600 x g for 10 min at 4°C. The supernatant fluid was discarded, and the cell pellet was resuspended in ice-cold saline containing 20 MLg of thymidine per ml.
The cells were collected on GF/B fiber-glass filters on a multiple membrane filter (Yeda Scientific Instruments, Rehovot, Israel), washed with the saline-thymidine solution, and acid precipitated with cold 5% trichloroacetic acid containing 20,g of thymidine per ml. The filters were then washed with 95% ethanol, dried for 30 min at 100°C, and placed in scintillation vials. Scintillation fluid [0.05% 1,4-bis-(5-phenyloxazolyl)benzene (POPOP) and 0.5% 2,5-diphenyloxazole (PPO) in toluene] was added, and radioactivity was counted with a Tri-Carb scintillation counter (Packard Instrument Co., Downers Grove, Ill.). Values presented are the mean of at least four experiments, each performed in triplicate. The standard deviations ranged between 3 and 5% in all cases.
The Coulter Counter method of counting lymphocytes and blast cells has been previously described (3, 10) . Samples from cultures were diluted 20-fold with Isoton (Coulter Electronics Inc., Herpenden, Hertfordshire, England) and counted in a Coulter Counter model ZF with an orifice of 100 ,m. The sensitivity control aperture current was set on 64, and amplification attenuation was set at 0. (24) . All cultures were incubated at 37°C and observed for 2 weeks. On days 3, 4, 5, and 6 of the incubation, 0.1-ml samples of each culture were withdrawn and plated on agar medium for the detection of mycoplasma colonies.
RESULTS
Activation of lymphocytes by M. pulmonis MP15. The lymphocyte transformation induced by our M. pulmonis isolate, MP15, has been described in previous publications (11; Ginsburg, Isr. J. Med. Sci. 10:1165, 1974 After the inoculation of fibroblast cultures with mycoplasma, the microorganism steadily increased in number. Overgrowth of mycoplasma in cell cultures was followed by a severe drop in pH, which could be detected optically by a red-to-yellow color change of the phenol red indicator present in the culture medium. This drop in pH was always accompanied by the death of fibroblast and lymphoid cells in culture.
To be able to control mycoplasma titers in cell cultures, it was found necessary to add chlortetracycline at concentrations that demonstrated an optimal bacteriostatic effect on all of the mycoplasma strains and species tested while being harmless to mammalian cells. Using this drug at concentrations that arrested any further mycoplasma multiplication, it was our experience that both thymidine incorporation by the microorganisms and target cell degeneration were prevented (unpublished data). Table 1 In control cultures, no thymidine incorporation was obtained either when rat lymphocytes were exposed to fibroblasts cultivated with mycoplasma-free modified Hayflick broth or by supernatants of inoculated fibroblast monolayers supplemented, parallel to experimental cultures, with tetracycline but without lymphocytes. It was thus confirmed that the thymidine incorporation into acid-precipitable material measured under these experimental conditions was due to lymphocyte proliferation, rather than incorporation by mycoplasma microorganisms.
Furthermore, it was observed previously (11) and in this study that mycoplasma microorganisms are very potent mitogens for rat lymphocytes but not for fibroblasts. Under our experimental conditions, confluent contact-inhibited embryo fibroblast monolayers inoculated with mycoplasma in the absence of lymphocytes incorporated virtually no [3H]thymidine, thus making irradiation of monolayers unnecessary.
Based on these results, the following procedure was adopted for obtaining lymphocyte transformation by infective mycoplasmas of various strains and species. Embryo fibroblast monolayers, 2 days old, were inoculated with mycoplasma particles (the titer being dictated by the individual experiment) and incubated for 24 h, during which period mycoplasma-propagated in the cell culture. Subsequently, 107 lymphocytes in 5 ml of Dulbecco medium containing 15% heat-inactivated horse serum and 100 ,ug of chlortetracycline were added. At this concentration the drug has been shown (unpublished data) to arrest any further multiplication and [3H]-thymidine uptake by all of the mycoplasma species tested in this study, thus avoiding thymidine incorporation by the microorganisms as well as lymphocyte and fibroblast degeneration.
Stimulation of rat lymphocytes by various strains of M. pulnonis. To determine whether mitogenicity is a property of various strains of M. pulmonis or restricted to our MP15 isolate, rat embryo fibroblast monolayers were inoculated with different M. pulmonis strains diluted to equal CFU titers. After 24 h of incubation, mycoplasma growth in cultures was arrested with chlortetracycline, and rat lymphocytes were exposed to the infected monolayers. From the results shown in Table 2 , it can be seen that the strongest lymphocyte stimulation was obtained in cultures infected with our MP15 isolate and with the Negroni strain of M. pulmonis. In addition to their mitogenicity, these two strains were also the only two that grew rapidly in the cultures. M. pulmonis JB did not multiply within the first 24 a Rat embryo fibroblast monolayers were prepared by plating 2 x 106 cells in 60-mm plastic petri dishes. Two days later, the monolayers were inoculated with mycoplasma or control broth in Dulbecco medium + 15% horse serum. The cultures were incubated for 24 h. Samples (0.1 ml) were assayed for the presence of infective mycoplasma. At 24 h, 10' lymphocytes in 5 ml of medium containing 20 ,ug of chlortetracycline per ml were added to each plate. ' Coulter Counter and [3H]thymidine uptake assays were performed 48 h after lymphocyte plating.
cultures containing certain mycoplasmas.
To determine whether the 24-h preincubation with fibroblasts might reduce the mitogenic potential of mycoplasmas that failed to survive as infective microorganisms^'a series ofexperiments was performed in which lymphocytes were plated simultaneously with the inoculation of fibroblast monolayers with mycoplasma. This experimental protocol did not detect any additional strains demonstrating mitogenic properties.
Blastogenesis induced by mycoplasma mitogens. The results described above demonstrate that mycoplasma species differ in the inoculation dose necessary to produce maximal transformation of rat lymphocytes. These differences were attributed to different capacities of the various M. pulmonis strains and other mycoplasmas to grow on fibroblast monolayers. To compare mitogenic potency of various mycoplasmas, it became necessary to substitute a preparation of killed mycoplasma exposed to an osmotic shock, as described in Materials and Methods, for infectious particles. Table 5 shows that a mycoplasma mitogen preparation from M. pulmonis MP15 is highly mitogenic for rat lymphocytes when compared with some potent mitogens such as phytohemagglutinin, concanavalin, and pokeweed mitogen. Rat lymphocytes exposed to optimal concentrations of mycoplasma mitogen undergo blast transformation to the same extent as those exposed to optimal titers of infective mycoplasma. Furthermore, the use of such mitogen preparations abolished the need for fibroblast monolayers required in pre- Lymph node and spleen cells from germfree rats were cultured in the presence of mycoplasma mitogen (final concentration, 20 ,ug of protein per ml). 10 of the well-documented serological differences between this mycoplasma and other murine mycoplasmas (7, 24) . Our data on the ability of M. pulmonis strains to activate human lymphocytes (unpublished data) add support to the conclusion that mycoplasmas induce a nonspecific transformation of lymphocytes. This conclusion is also supported by the report by Biberfeld and Gronowicz (4), which clearly shows polyclonal activation of mouse B-lymphocytes by the human mycoplasma M. pneumoniae.
M. pulmonis, M. neurolyticum, and M. arthritidis are murine mycoplasmas and, with rare exceptions, have been isolated only from mice and rats (24) . Two of these species, M. pulmonis and M. arthritidis, can be found as latent agents in both hosts, whereas M. neurolyticum occurs as a latent infection only in mice. Although latent infections predominate with these murine mycoplasmas, they can, under appropriate conditions of host stress, assume a clearly pathogenic role. Overt infections can vary from chronic respiratory disease, polyarthritis, and conjunctivitis to a fatal neurological disease (1, 6, 16, 22) . Experimentally, polyarthritis is produced in mice by intraperitoneal inoculation of M. pulmonis (1, 20) and in rats by inoculation of M. arthritidis (5) . The present study raises the questions of whether there is a correlation between pathogenicity and the mitogenic property of mycoplasmas and whether such a mitogenicity is protective or, alternatively, represents a pathological manifestation. No answer is yet available. However, studies aimed at elucidating whether pathogenicity of mycoplasmas is exerted by lymphokines produced during lymphocyte proliferation, together with studies on the relationship between antigenicity and mitogenicity of mycoplasma mitogens, are in progress.
